Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
adult, ago, analyze, antagonist, antiretroviral, ATP, BLA, box, British, buy, Chinese, CHO, cleveland, cohort, CompoZrTM, Conference, deny, dollar, domiciled, DSMB, editing, evergreen, EXZACTTM, Facet, feature, fusion, Glutamine, growing, GS, HAART, Hamster, harbor, Harmonisation, illustrate, indirectly, instability, integrase, investee, length, linker, liver, lump, maraviroc, microRNA, mimicking, NDA, nonfinancial, Nonmonetary, OMT, Ovary, paul, placebo, post, pound, preferential, problem, prohibit, protease, readily, reagent, recommend, recurring, reexamination, responding, Roche, RT, SB, Selzentry, situation, sum, sural, Synthetase, TherapeuticsTM, throughput, transcriptase, turmoil, UK, Unadjusted, undetectable, unobservable, unrestricted, Visiongain, vitro, vivo, warning, worth, zebrafish
Removed:
absence, allocation, angioplasty, apply, arterial, asymptomatic, attention, auditor, call, cardiovascular, claudication, CLI, compel, component, criterion, distance, doubled, Duke, Eighty, evolution, fewer, forin, headcount, heart, hospital, IC, intermittent, ischemia, LifeScan, Lung, medicine, NHLBI, optimize, PAD, prevailing, prevalence, principally, receipt, reducing, representation, resource, resting, signaling, Society, vitroandin
Filing tables
Filing exhibits
- 10-K Annual report
- 10.25 License Agreement Between Sangamo and Pfizer Inc, Dated December 19, 2008
- 10.26 Amended and Restated Employment Agreement
- 10.27 First Amendment to Employment Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Certification of Chief Executive Officer
- 31.2 Rule 13A-14(A) Certification of Principal Financial Officer
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
Related press release
SGMO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-34196, 333-64642 and 333-132823) and in the Registration Statements (Form S-3 No. 333-113062 and 333-68066 and 333-134516) and in the related prospectuses of Sangamo BioSciences, Inc. of our reports dated March 2, 2009, with respect to the consolidated financial statements of Sangamo BioSciences, Inc., and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2008.
/s/ ERNST & YOUNG LLP |
Palo Alto, California
March 2, 2009